VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

BACKGROUND: Combination of fluoropyrimidines and a platinum derivative are currently standards for systemic chemotherapy in advanced adenocarcinoma of the stomach and gastroesophageal junction (GEJ). Nevertheless, individual likelihood for response to these therapeutic regimes remains uncertain. Eve...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomaidis, Thomas, Maderer, Annett, Al-Batran, Salah-Eddin, Kany, Janis, Pauligk, Claudia, Steinmetz, Kristina, Schad, Arno, Hofheinz, Ralf, Schmalenberg, Harald, Homann, Nils, Galle, Peter Robert, Moehler, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094395/
https://www.ncbi.nlm.nih.gov/pubmed/24981311
http://dx.doi.org/10.1186/1471-2407-14-476

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094395/
https://www.ncbi.nlm.nih.gov/pubmed/24981311
http://dx.doi.org/10.1186/1471-2407-14-476

Ejemplares similares